INNOVATE (VATE) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
11 Jun, 2026Opening remarks and agenda
Meeting called to order with board members and executive officers introduced.
Attendees welcomed and informed about the Q&A session following the meeting.
Agenda and rules of conduct made available on the meeting site.
Board and executive committee updates
Board members present included Avi Glazer, Warren Gfeller, Brian Goldstein, and Amy Wilkinson.
Interim CEO Paul Voigt and CFO Michael Sena were introduced.
Shareholder proposals
Four proposals presented: election of directors, advisory vote on executive compensation, amendment to equity award plan, and ratification of accounting firm.
No other nominations for directors were submitted.
Partial view of Summaries dataset, powered by Quartr API
Latest events from INNOVATE
- Revenue up 33% to $364.8M, net loss narrowed, but debt maturities pose going concern risk.VATE
Q1 202620 May 2026 - Annual meeting to vote on directors, compensation, equity plan, and auditor ratification.VATE
Proxy filing28 Apr 2026 - Board recommends FOR all proposals, with focus on growth, governance, and executive alignment.VATE
Proxy filing28 Apr 2026 - Q4 2025 revenue up 61.7% to $382.7M, with strong Infrastructure growth and narrowing net loss.VATE
Q4 202526 Mar 2026 - Q2 net income rose to $14.4M as margins improved and Life Sciences posted record sales.VATE
Q2 20242 Feb 2026 - Q3 revenue dropped 35.5% to $242.2M; growth in Life Sciences and Spectrum, but going concern risk remains.VATE
Q3 202416 Jan 2026 - Revenue declined, but Life Sciences and Spectrum grew; debt reduced and backlog remains strong.VATE
Q4 202425 Dec 2025 - Annual meeting to vote on directors, executive pay, auditor, and governance after major 2024 changes.VATE
Proxy Filing2 Dec 2025 - Director elections, say-on-pay, and auditor ratification up for vote at June 2025 meeting.VATE
Proxy Filing2 Dec 2025